Opinion

Gilead Sciences Bets $400M On Inflammatory Diseases Focused UK Based Firm

Gilead Sciences Inc (NASDAQ: GILD) has agreed to acquire MiroBio, a privately-held U.K.-based biotechnology company focused on restoring immune …

Read more

Show More

Related Articles

Back to top button